Historial del iniciado
OtroTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the complete record of transactions filed by Patience David. Director active across 2 companies, notably Accelerate Diagnostics, Inc. Cumulatively, 21 filings have been logged. Split: 0 buy · 4 sells. Total volume traded: €2k. History available since 13 April 2023. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Patience David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones21 en total
14.650 títulos@ 4,46 US$0.023% mcap100.0% de su flujoCommon StockSEC:0001628280-26-047217:0
65.000 títulos0Common StockSEC:0001970009-25-000004:0
200.000 títulos0Common StockSEC:0001826667-25-000121:0
20.000 títulos0Common StockSEC:0001104659-25-031298:0
1500 títulos0Common StockSEC:0001104659-25-018521:0
37.468 títulos0Common StockSEC:0001104659-24-045899:0
1000 títulos0Common StockSEC:0001104659-24-028325:0
350 títulos@ 0,96 US$14.2% de su flujoCommon StockSEC:0001104659-24-028325:1
16.666 títulosCommon StockSEC:0001104659-24-006671:0
331 títulos0Common StockSEC:0001104659-23-126067:0
331 títulos0Common StockSEC:0001104659-23-118221:0
97 títulos@ 5,57 US$23.1% de su flujoCommon StockSEC:0001104659-23-118221:1
331 títulos0Common StockSEC:0001628280-23-034442:0
331 títulos0Common StockSEC:0001104659-23-100789:0
331 títulos0Common StockSEC:0001628280-23-029596:0
95 títulos@ 6,80 US$27.1% de su flujoCommon StockSEC:0001628280-23-029596:1
330 títulos0Common StockSEC:0001628280-23-025009:0
3309 títulos0Common StockSEC:0001628280-23-022178:0
3309 títulos0Common StockSEC:0001628280-23-018496:0
1222 títulos@ 0,69 US$35.5% de su flujoCommon StockSEC:0001628280-23-018496:1
3309 títulos0Common StockSEC:0001628280-23-011840:0
About Patience David
Patience David has filed 18 forms in total. Across the 18 recent sampled filings between 2023-04-17 and 2025-04-02, sales total EUR 2183 and the stated transaction nature is option exercise. She is listed as Chief Financial Officer at Accelerate Diagnostics, Inc.